Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 4/20 | 0.43 |
| ▸ | HTR1D | P28221 | 15/20 | 0.42 |
| ▸ | HTR1B | P28222 | 13/20 | 0.42 |
| ▸ | HTR1A | P08908 | 2/20 | 0.42 |
| ▸ | HTR1F | P30939 | 2/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8382108 | 0.84 | SLC6A4 (0.46) | SLC6A4HTR1DHTR1BHTR1AHTR1F | |
| SCHEMBL8725963 | 0.82 | HTR1D (0.44) | SLC6A4HTR1DHTR1BHTR1AHTR1F | |
| SCHEMBL8383553 | 0.81 | SLC6A4 (0.45) | SLC6A4HTR1DHTR1BHTR1AHTR1F | |
| SCHEMBL8724037 | 0.81 | HTR1D (0.47) | SLC6A4HTR1DHTR1BHTR1AHTR1F | |
| SCHEMBL8382954 | 0.81 | HTR1D (0.44) | SLC6A4HTR1DHTR1BHTR1AHTR1F | |
| SCHEMBL8709412 | 0.81 | SLC6A4 (0.52) | SLC6A4HTR1DHTR1BHTR1AHTR1F | |
| SCHEMBL8381747 | 0.80 | NOS3 (0.40) | SLC6A4HTR1DHTR1B | |
| SCHEMBL7485929 | 0.79 | HTR1D (0.52) | HTR1DHTR1BHTR1AHTR1FCHRM2 | |
| SCHEMBL8386435 | 0.78 | HTR1D (0.47) | SLC6A4HTR1DHTR1BHTR1AHTR1F | |
| SCHEMBL8383598 | 0.78 | SLC6A4 (0.47) | SLC6A4HTR1DHTR1BHTR1AHTR1F |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5874427-A | MIGRAINE | ELI LILLY AND COMPANY (US) | 1999-02-23 | — | — | US | disclosed |
| EP-0875513-A1 | Substituted heteroaromatic 5-HT 1F agonists | ELI LILLY AND COMPANY (US) | 1998-11-04 | — | — | EP | disclosed |